REG - GlaxoSmithKline PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">GSK.L</Origin>

GSKAnnouncement

20/10/2017 16:11

RNS Number : 2483U
GlaxoSmithKline PLC
20 October 2017
GlaxoSmithKline plc(the'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr N Hirons
b)
Position/status
SVP, Global Ethics & Compliance
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
GlaxoSmithKline plc American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Natureofthetransaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 October 2017.
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
$41.1310
17.483
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-19
f)
Placeofthe transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr B McNamara 
b)
Position/status
CEO, Consumer Healthcare
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Natureofthetransaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 October 2017.
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
$41.1310
207.139
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-19
f)
Placeofthe transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D E Troy 
b)
Position/status
SVP & General Counsel
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Natureofthetransaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 October 2017.
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
$41.1310
1,627.113
d)
Aggregatedinformation
AggregatedvolumePrice
n/a (single transaction)
e)
Date ofthetransaction
2017-10-19
f)
Placeofthe transaction
New York Stock Exchange (XNYS)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHEBLFLDBFBFBQ